Display options
Share it on

Diseases. 2021 May 28;9(2). doi: 10.3390/diseases9020040.

Negative Fat Pad Biopsy in Systemic AL: A Case Report Analyzing the Preferred Amyloidosis Screening Test.

Diseases (Basel, Switzerland)

Kelsey Hummel, Hany Meawad, William T Gunning, Amira F Gohara

Affiliations

  1. Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.
  2. City of Hope Laboratories, Duarte, CA 91010, USA.
  3. Department of Pathology, University of Toledo Medical Center, Toledo, OH 43614, USA.

PMID: 34071274 PMCID: PMC8161780 DOI: 10.3390/diseases9020040

Abstract

Light chain amyloidosis (AL) causes irreversible multi-organ damage if not diagnosed early in the disease process. Fat pad biopsy is thought to be a highly sensitive screening test in systemic AL cases, especially if greater than three organs are involved. We present a case of a 64-year-old female who was admitted to the hospital with worsening heart and kidney failure, anasarca, increased free serum lambda light chains, and a negative fat pad biopsy for amyloidosis. Later, she developed asystole, bradycardia, severe hypotension, and respiratory distress. Because X-rays of her calvarium showed multiple osteolytic lesions, a bone marrow biopsy was planned to assess for multiple myeloma. Due to her non-reassuring vitals, the biopsy was not attempted, and she passed away several weeks later. Autopsy findings identified the cause of death as multiple system organ failure due to systemic AL. Through microscopic examination, pathologists found amyloid deposits in her heart, kidneys, rectum, thyroid, adrenals, bone marrow, liver, and spleen. Postmortem fat pad biopsy was negative; however, bone marrow biopsy demonstrated clusters of CD138-positive cells, confirming plasma cell dyscrasia. In cases with a negative fat pad biopsy, an additional superficial or involved organ biopsy should be pursued to establish a diagnosis of amyloidosis if strong clinical suspicion exists.

Keywords: AL; amyloidosis; autopsy; biopsy; bone marrow; fat pad; negative; rectal

References

  1. Hum Pathol. 2018 Feb;72:71-79 - PubMed
  2. Nat Rev Dis Primers. 2018 Oct 25;4(1):38 - PubMed
  3. Br J Haematol. 2016 Jan;172(2):170-86 - PubMed
  4. Eur Heart J. 2017 Jun 21;38(24):1905-1908 - PubMed
  5. Patient. 2018 Apr;11(2):207-216 - PubMed
  6. Arch Intern Med. 1983 Aug;143(8):1549-52 - PubMed
  7. Rheumatology (Oxford). 2015 Nov;54(11):2109-11 - PubMed
  8. Cytojournal. 2020 Jun 20;17:15 - PubMed
  9. Arthritis Rheum. 1989 Jan;32(1):82-5 - PubMed
  10. PLoS One. 2017 Sep 19;12(9):e0185078 - PubMed
  11. J Intern Med. 2021 Mar;289(3):268-292 - PubMed
  12. Int J Mol Sci. 2019 Mar 14;20(6): - PubMed
  13. Case Rep Nephrol. 2012;2012:593460 - PubMed
  14. Arch Intern Med. 1988 Apr;148(4):929-33 - PubMed
  15. J Vis Exp. 2010 Oct 30;(44): - PubMed
  16. Hippokratia. 2008;12(4):236-9 - PubMed
  17. FEBS J. 2005 Dec;272(23):5950-61 - PubMed
  18. Rheum Dis Clin North Am. 2018 Nov;44(4):585-603 - PubMed
  19. Arthritis Care Res (Hoboken). 2010 Mar;62(3):296-301 - PubMed
  20. Curr Med Chem. 2012;19(15):2304-11 - PubMed
  21. Cytojournal. 2011;8:11 - PubMed
  22. Arthritis Rheum. 2006 Jun;54(6):2015-21 - PubMed

Publication Types